Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇹🇷TR · Business#703K to 10K
- 🇭🇰HK · Business#111500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.1K to 3.9K🎙 Daily cadence·402 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
3.5K to 13K🇹🇷77%🇭🇰23% - Active Followers
Loyal subscribers who consistently listen
1.1K to 3.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 21 epsHosts
Recent guests
Recent episodes
409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
Jul 16, 2026
35m 32s
408: Whistleblower takes on health insurance and FDA commissioner candidates
Jul 9, 2026
43m 58s
407: The mysterious case of Eli Lilly's obesity drug
Jun 25, 2026
42m 45s
406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises
Jun 18, 2026
36m 10s
405: An obesity drug deep-dive, and peptides move mainstream
Jun 11, 2026
36m 26s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/16/26 | biotechclinical trials+4 | Jonathan Kimmelman | tau-lowering drugKalshi+2 | McGill University | biotechclinical trials+6 | — | 35m 32s | ||
| 7/9/26 | health insurancewhistleblower+5 | Bob HermanChris Deacon | STATAnthropic+2 | New Jersey | health insurance costswhistleblower lawsuit+5 | — | 43m 58s | ||
| 6/25/26 | obesity drugFDA+4 | Lizzy Lawrence | retatrutideEli Lilly+1 | — | Eli Lillyobesity drug+6 | — | 42m 45s | ||
| 6/18/26 | Huntington's diseasegene therapy+4 | Lauren HolderIsabella Cueto | UniQureSTAT+2 | — | Huntington's diseasegene therapy+5 | — | 36m 10s | ||
| 6/11/26 | obesity medicationspeptides+4 | Sara Talpos | BPC-157STAT+2 | — | obesitypeptides+5 | — | 36m 26s | ||
| 6/4/26 | pancreatic cancerbiotech stocks+4 | Leanna Stokes | daraxonrasibRevolution Medicines+3 | — | pancreatic cancerdaraxonrasib+6 | — | 37m 49s | ||
| 5/28/26 | biotechindustry strategy+3 | Jeremy Levin | STATBiotech in the Balance: Saving a Strategic Industry in an Age of Distrust | — | biotechindustry+4 | — | 47m 22s | ||
| 5/21/26 | biotechlongevity+4 | Joe Betts-LaCroix | BridgeBioRetro Biosciences+1 | China | biotechlongevity+5 | — | 44m 08s | ||
| 5/14/26 | health politicsFDA+3 | Lizzy LawrenceChelsea Cirruzzo | FDASTAT | — | health politicsFDA+6 | — | 40m 43s | ||
| 5/7/26 | biotech IPOobesity treatment+3 | Daphne Zohar | Seaport TherapeuticsEli Lilly+2 | — | Seaport TherapeuticsIPO+6 | — | 33m 09s | ||
| 4/30/26 | hair loss drugsclinical trials+3 | Reid WaldmanDavid Lee | VeradermicsServier Pharmaceuticals+1 | — | hair lossclinical trials+4 | — | 41m 26s | ||
| 4/23/26 | biotech acquisitionCAR-T therapy+4 | Bryan RobertsKatie Palmer | Kelonia TherapeuticsEli Lilly+2 | — | biotechM&A+5 | — | 37m 50s | ||
| 4/16/26 | pancreatic cancerCAR-T therapy+3 | Zach RobertsPaul Oberstein | Allogene TherapeuticsRevolution Medicines+1 | B-cell lymphomapancreatic cancer | pancreatic cancerCAR-T treatment+5 | — | 49m 47s | ||
| 4/9/26 | biotechventure capital+4 | Jason Mast | PhRMAFood and Drug Administration+4 | — | biotechventure capital+6 | — | 32m 12s | ||
| 4/2/26 | biotech investmentFDA decisions+4 | Rod Wong | obesity pillsleep medicine+3 | — | biotechFDA+5 | — | 31m 58s | ||
| 3/26/26 | biotechpharma+5 | — | Eli LillyMerck+3 | — | Eli LillyMerck+6 | — | 25m 52s | ||
| 3/20/26 | biotechweight loss+3 | Stelios Papadapolous | Structure TherapeuticsEli Lilly+1 | New York City | biotechStelios Papadapolous+4 | — | 45m 05s | ||
| 3/12/26 | biotech investmentFDA+4 | Damian Garde | FDANovo Nordisk+2 | — | biotechFDA+7 | — | 30m 51s | ||
| 3/5/26 | inflammatory bowel diseasedrug efficacy+3 | Cameron Turtle | Food and Drug AdministrationSpyre Therapeutics+2 | — | IBDdrugmakers+5 | — | 30m 29s | ||
| 2/26/26 | biotech stock performanceM&A+3 | Jared Holz | Mizuho SecuritiesFood and Drug Administration | — | FDAbiotech+5 | — | 32m 40s | ||
| 2/19/26 | Hims Super Bowl adFDA regulations+3 | Katie Palmer | HimsFDA+2 | — | HimsFDA+5 | — | 34m 20s |
Showing 21 of 21
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for The Readout Loud
Peaked at #70 in TR, currently #70 in TR.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TR | — | #70 | #70 | — |
| HK | — | #111 | #111 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.